BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
Biohit Oyj Financial Statement Release, 20 February 2019 at 9:30 am local time (EET) SUMMARY January-December 2018 · Net sales EUR 9.9 million (EUR 9.0 million) · Net sales grew by 10.6% compared to 2017 · Operative EBITDA EUR -0.1 million (EUR -0.4 million) · Cash at the end of the period EUR 1.4 million (EUR 1.3 million) · Net sales from international operations 95.6% (95.7%) of total net sales · Equity ratio 89.2% (91.3%) July-December 2018 · Net sales EUR 5.0 million (EUR 4.9 million) · Net sales grew by 2.0% compared to H2/2017 · Operative EBITDA